Cargando…

An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.

Detalles Bibliográficos
Autor principal:	Pimm, M. V.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971737/ https://www.ncbi.nlm.nih.gov/pubmed/2390485

Ejemplares similares

Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
por: Harwood, P. J., et al.
Publicado: (1985)

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
por: Hird, V., et al.
Publicado: (1991)

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
por: Bruland, O., et al.
Publicado: (1987)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

Serological aspects of rat tumour xenograft growth in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1979)

Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.
por: Moshakis, V., et al.
Publicado: (1981)

Monoclonal Antibodies and Cancer - Immunology Series - Vol. 23
por: Pimm, M.V.
Publicado: (1985)

Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990)

Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983)

Cerebral blood flow in critically ill cardiac patients: effects of vasoactive drug therapy
por: El-Atroush, H, et al.
Publicado: (2002)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.
por: Cowled, P. A., et al.
Publicado: (1989)

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
por: Modjtahedi, H., et al.
Publicado: (1996)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1991)

Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.
por: Dworkin, M. J., et al.
Publicado: (1997)

Weaning order of vasoactive drugs
por: Michels, Vilto, et al.
Publicado: (2019)

Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
por: Price, M. R., et al.
Publicado: (1982)

Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986)

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
por: Pimm, M. V., et al.
Publicado: (1990)

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
por: Kievit, E., et al.
Publicado: (1996)

Response to “Weaning order of vasoactive drugs”
por: Jeon, Kyeongman, et al.
Publicado: (2019)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

Localisation of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product.
por: Chan, S. Y., et al.
Publicado: (1986)

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
por: Boxer, G. M., et al.
Publicado: (1994)

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT(R))
por: De Santis, R, et al.
Publicado: (2003)

In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
por: Bremner, J. C., et al.
Publicado: (1991)

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.
por: Sharma, S. K., et al.
Publicado: (1990)

Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery
por: Brunstein, F, et al.
Publicado: (2006)

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
por: Pedley, R. B., et al.
Publicado: (1994)

Red Blood Cell Deformability, Vasoactive Mediators, and Adhesion
por: McMahon, Timothy J.
Publicado: (2019)

Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.
por: Rogers, G. T., et al.
Publicado: (1986)

Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
por: Qriouet, Zidane, et al.
Publicado: (2021)

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
por: Chamorro, Sonia, et al.
Publicado: (2014)

Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity.
por: Pimm, M. V., et al.
Publicado: (1976)

Influence of orally administered B.C.G. on growth of transplanted rat tumours.
por: Baldwin, R. W., et al.
Publicado: (1975)

Proceedings of an international workshop on monoclonal antibodies to tumour antigens.
Publicado: (1981)

Monoclonal antibody‐mediated killing of tumour cells by neutrophils
por: Heemskerk, Niels, et al.
Publicado: (2018)

Iodinated hydroxyphenyl and hydroxynaphthyl porphyrins as tumour localisers.
por: Zanelli, G. D., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_7gpnjahqr2a0gq79me2scbp4d2